Last reviewed · How we verify
Chloroprocaine 3% — Competitive Intelligence Brief
phase 3
Local anesthetic (ester)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Chloroprocaine 3% (Chloroprocaine 3%) — Sintetica SA. Chloroprocaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of nerve impulses.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chloroprocaine 3% TARGET | Chloroprocaine 3% | Sintetica SA | phase 3 | Local anesthetic (ester) | Voltage-gated sodium channels | |
| Anesthetics, Local | Anesthetics, Local | University of Alberta | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Infiltration - EXPAREL | Infiltration - EXPAREL | Pacira Pharmaceuticals, Inc | marketed | Long-acting local anesthetic | Voltage-gated sodium channels | |
| Lidocaine 2% Injectable Solution | Lidocaine 2% Injectable Solution | Erasme University Hospital | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Lidocaine 2% Jelly | Lidocaine 2% Jelly | Hermann Eye Center | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Levobupivacaine and Fentanyl | Levobupivacaine and Fentanyl | Hamad Medical Corporation | marketed | Local anesthetic with opioid analgesic combination | Voltage-gated sodium channels; mu-opioid receptor | |
| Lidocaine plus adrenaline | Lidocaine plus adrenaline | University of Santiago de Compostela | marketed | Local anesthetic with vasopressor | Voltage-gated sodium channels; alpha-1 and beta-1 adrenergic receptors |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (ester) class)
- Sintetica SA · 4 drugs in this class
- Centre Hospitalier Universitaire Saint Pierre · 1 drug in this class
- Nova Scotia Health Authority · 1 drug in this class
- American Genomics, LLC · 1 drug in this class
- University of Miami · 1 drug in this class
- Wenzhou Medical University · 1 drug in this class
- Oregon Health and Science University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chloroprocaine 3% CI watch — RSS
- Chloroprocaine 3% CI watch — Atom
- Chloroprocaine 3% CI watch — JSON
- Chloroprocaine 3% alone — RSS
- Whole Local anesthetic (ester) class — RSS
Cite this brief
Drug Landscape (2026). Chloroprocaine 3% — Competitive Intelligence Brief. https://druglandscape.com/ci/chloroprocaine-3. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing